Crossmark

Caracterización del uso de tofacitinib como tratamiento para COVID-19

Published Print: 2022-06

Authors

Toribio Polanco, Fidel José

García Delgado, Annette Giselle

Reyes Cruz, Cinthia Yamel

Cabrera Castellanos, Osvaldo de Jesús

Alejo Ramos, Paola Gissel

Khoury, Vianna

García, Natalia
License Information

Text and Data Mining valid from 2022-06-01

Text and Data Mining valid from 2022-06-01
More Information

This article is maintained by: Elsevier

Article Title: Caracterización del uso de tofacitinib como tratamiento para COVID-19

Journal Title: Revista Colombiana de Reumatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreu.2022.03.002

Content Type: article

Copyright: © 2022 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.

Document is current